A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers

American Journal of Gastroenterology

Volumn 96, Issue 2, 2001, Pages 367-372

  Phillips, Jeffrey O ^a   Olsen, Keith M ^b   Rebuck, Jill A ^b   Rangnekar, Nick J ^a   Miedema, Brent W ^a   Metzler, Michael H ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; PH MEASUREMENT; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH PH; STRESS ULCER;

ADULT; ANTI-ULCER AGENTS; CRITICAL ILLNESS; CROSS-OVER STUDIES; DUODENUM; FEMALE; HUMANS; INTUBATION, GASTROINTESTINAL; JEJUNUM; MALE; OMEPRAZOLE; PEPTIC ULCER; STRESS;

EID: 0035123898     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02315-7     Document Type: Article

References (26)

1. Changing perspectives of stress gastritis prophylaxis
2. Prophylactic therapy for stress ulcer bleeding: A reappraisal
3. 2 receptor antagonists as a single intravenous dose on gastric pH and volume in critically ill patients
4. Twenty-four-hour intragastric pH: Tolerance within 5 days of continuous ranitidine administration
5. +-ATPase isolated from human gastric mucosa
6. Effect of omeprazole on gastric acid secretion
7. +, ATPase as a therapeutic target
8. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis
9. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage
10. A multicenter, prospective, randomized clinical trial of continuous infusion intravenous ranitidine vs. omeprazole suspension in the prophylaxis of stress ulcers
11. Stability of omeprazole in an extemporaneously prepared oral liquid
12. Stability of liquid formulations of lansoprazole and omeprazole stored in amber-colored plastic syringes
13. Pharmacodynamics of omeprazole suspension in critically ill pediatric liver/intestinal transplant patients
14. Bioavailability and efficacy of omeprazole given orally and by nasogastric tube
15. Nasogastric omeprazole: Effects on gastric pH in critically ill patients
16. High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine
17. +)-ATPase within the parietal cell
18. Controlling gastric pH: The impact of newer agents on the critically ill patient
19. Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects
20. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole, and pantoprazole
21. Effect of omeprazole - A gastric proton pump inhibitor - On pentagastrin stimulated acid secretion in man
22. Twenty-four hour intragastric acidity during treatment with oral omeprazole
23. Omeprazole-induced increase in absorption of bismuth from tripotassium dicitrato bismuthate
24. Effect of omeprazole 40 mg once daily on intraduodenal and intragastric pH in H. pylori-negative healthy subjects
25. Absorption of omeprazole is significantly impaired when given as simplified omeprazole suspension (SOS)
26. 2 antagonists on gastric volume and pH